Document is current
Any future updates will be listed below
-
Authors
Fortunato, Angelo
Mallo, Diego
Cisneros, Luis
King, Lorraine M.
Khan, Aziz
Curtis, Christina
Ryser, Marc D.
Lo, Joseph Y.
Hall, Allison
Marks, Jeffrey R.
Hwang, E. Shelley
Maley, Carlo C.
-
Funding
Funding for this research was provided by:
National Institutes of Health (U54 CA217376, U2C CA233254, U54 CA217376)
Congressionally Directed Medical Research Programs (BC132057)
Arizona Biomedical Research Commission (ADHS18-198847)
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 19 January 2025
First Online: 21 March 2025
Declarations
:
: The Institutional Review Board (IRB) of Duke University Medical Center, as well as the IRB at each participating institution, approved this study, and a waiver of consent was obtained according to the approved protocol.
: Not applicable.
: CC serves on the Scientific Advisory Board and/or as consultant for Bristol Myers Squibb, Deepcell, Genentech, NanoString, Ravel, Viosera, and holds equity in Deepcell, Illumina/Grail, and Ravel.
